- Tekmira Pharma (NASDAQ:TKMR) +4.2% AH following a Daily Mail story suggesting it is a takeover candidate, after shares have nearly doubled in the past month thanks to attention over its experimental treatment for the deadly ebola virus.
- Rumors suggest interested parties could include Shire (NASDAQ:SHPG) and GlaxoSmithKline (NYSE:GSK); the report suggests the recent premium paid for InterMune could put a valuation of at least $40/share on TKMR.
From other sites
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Jan 13, 2015)
at MarketWatch.com (Jan 12, 2015)
at Benzinga.com (Jan 12, 2015)
at Investor's Business Daily (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs